Broadwood Partners opposes STAAR Surgical sale to Alcon
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff pulls Wall Street to two-week lows as oil and yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Tech selloff pulls Wall Street to two-week lows as oil and yields climb
- Francisco Partners to acquire Weave Communications for $650M
Broadwood Partners Publishes Presentation Detailing Opposition to STAAR Surgical’s Sale to Alcon
October 3, 2025 6:00 AM EDTBroadwood Believes the Transaction Comes at the Wrong Time, After the Wrong Process, and at the Wrong Price
For the Reasons Described in the Presentation, Broadwood Urges All Stockholders to Vote AGAINST the Proposed Merger
NEW YORK--(BUSINESS WIRE)-- Broadwood Partners, L.P. and its affiliates (collectively, Broadwood), holders of approximately 27.5% of the outstanding common stock of STAAR Surgical Company (STAAR or the Company) (NASDAQ: STAA), today announced that it has published a presentation outlining why stockholders should vote on Broadwoods... More
